Globus Medical ROA 2010-2018 | GMED
Current and historical return on assets (ROA) values for Globus Medical (GMED) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Globus Medical ROA for the three months ending September 30, 2018 was 14.02%.
Globus Medical ROA - Return on Assets Historical Data | |||
---|---|---|---|
Date | TTM Net Income | Total Assets | Return on Assets |
2018-09-30 | $0.14B | $1.24B | 12.41% |
2018-06-30 | $0.14B | $1.19B | 12.17% |
2018-03-31 | $0.12B | $1.13B | 11.23% |
2017-12-31 | $0.11B | $1.08B | 10.61% |
2017-09-30 | $0.11B | $1.04B | 11.02% |
2017-06-30 | $0.11B | $1.00B | 11.41% |
2017-03-31 | $0.11B | $0.96B | 11.48% |
2016-12-31 | $0.10B | $0.93B | 11.75% |
2016-09-30 | $0.12B | $0.90B | 13.70% |
2016-06-30 | $0.12B | $0.87B | 14.11% |
2016-03-31 | $0.12B | $0.84B | 14.32% |
2015-12-31 | $0.11B | $0.83B | 14.38% |
2015-09-30 | $0.10B | $0.80B | 13.67% |
2015-06-30 | $0.10B | $0.77B | 13.99% |
2015-03-31 | $0.10B | $0.74B | 14.31% |
2014-12-31 | $0.09B | $0.70B | 14.49% |
2014-09-30 | $0.09B | $0.65B | 14.16% |
2014-06-30 | $0.08B | $0.62B | 14.38% |
2014-03-31 | $0.07B | $0.60B | 12.61% |
2013-12-31 | $0.07B | $0.57B | 13.18% |
2013-09-30 | $0.07B | $0.53B | 13.99% |
2013-06-30 | $0.06B | $0.50B | 13.95% |
2013-03-31 | $0.08B | $0.47B | 17.84% |
2012-12-31 | $0.07B | $0.45B | 18.68% |
2012-09-30 | $0.07B | $0.42B | 18.27% |
2012-06-30 | $0.07B | $0.37B | 25.88% |
2012-03-31 | $0.06B | $0.36B | 36.26% |
2011-12-31 | $0.06B | $0.33B | 68.09% |
2011-09-30 | $0.04B | $0.00B | 62.92% |
2011-06-30 | $0.03B | $0.00B | 37.45% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Instruments Manufacturing | $4.618B | $0.636B |
Globus Medical, Inc. is a medical device company focused on the design, development and commercialization of products that promote healing in patients with spine disorders. The Company's products fall into one of two categories: innovative fusion or disruptive technologies. Its innovative fusion products address a broad range of spinal fusion surgical procedures. Its disruptive technology products include minimally invasive surgical, motion preservation and advanced biomaterials technologies. Globus Medical, Inc. is based in Audubon, Pennsylvania. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Thermo Fisher Scientific (TMO) | United States | $99.090B | 22.14 |
Intuitive Surgical (ISRG) | United States | $61.375B | 57.77 |
Edwards Lifesciences (EW) | United States | $36.818B | 37.47 |
Fresenius Medical Care AG KGaA (FMS) | Germany | $23.351B | 15.79 |
IDEXX Laboratories (IDXX) | United States | $17.845B | 48.46 |
ABIOMED (ABMD) | United States | $16.133B | 106.49 |
Hologic (HOLX) | United States | $13.176B | 19.92 |
DexCom (DXCM) | United States | $13.134B | 0.00 |
Teleflex (TFX) | United States | $12.945B | 29.39 |
Varian Medical Systems (VAR) | United States | $11.962B | 29.88 |
STERIS (STE) | United Kingdom | $10.238B | 26.31 |
Masimo (MASI) | United States | $6.826B | 44.26 |
Penumbra (PEN) | United States | $5.298B | 319.88 |
LivaNova (LIVN) | United Kingdom | $4.597B | 29.51 |
Integra LifeSciences Holdings (IART) | United States | $4.314B | 21.02 |
Wright Medical Group (WMGI) | Netherlands | $3.921B | 0.00 |
Cantel Medical (CMD) | United States | $3.443B | 33.96 |
Inogen (INGN) | United States | $2.952B | 63.71 |
Tandem Diabetes Care (TNDM) | United States | $2.827B | 0.00 |
Integer Holdings (ITGR) | United States | $2.611B | 21.85 |
Glaukos (GKOS) | United States | $2.400B | 0.00 |
AVANOS MEDICAL, INC (AVNS) | United States | $2.244B | 20.22 |
OPKO Health (OPK) | United States | $1.636B | 0.00 |
Nevro (NVRO) | United States | $1.476B | 0.00 |
Tactile Systems Technology (TCMD) | United States | $1.283B | 204.24 |
ORTHOFIX MEDICAL INC (OFIX) | United States | $1.205B | 34.81 |
Luminex (LMNX) | United States | $1.138B | 52.10 |
Pacific Biosciences Of California (PACB) | United States | $1.059B | 0.00 |
Accelerate Diagnostics (AXDX) | United States | $1.038B | 0.00 |
Intersect ENT (XENT) | United States | $0.992B | 0.00 |
CryoLife (CRY) | United States | $0.956B | 103.40 |
Natus Medical (BABY) | United States | $0.904B | 18.85 |
Mesa Laboratories (MLAB) | United States | $0.894B | 36.57 |
AngioDynamics (ANGO) | United States | $0.860B | 27.89 |
ViewRay (VRAY) | United States | $0.752B | 0.00 |
Veracyte (VCYT) | United States | $0.730B | 0.00 |
AxoGen (AXGN) | United States | $0.687B | 0.00 |
Quotient (QTNT) | Switzerland | $0.652B | 0.00 |
TransEnterix (TRXC) | United States | $0.586B | 0.00 |
OrthoPediatrics (KIDS) | United States | $0.458B | 0.00 |
Si-Bone (SIBN) | United States | $0.441B | 0.00 |
Accuray (ARAY) | United States | $0.423B | 0.00 |
Oxford Immunotec Global (OXFD) | United Kingdom | $0.406B | 0.00 |
Fluidigm (FLDM) | United States | $0.405B | 0.00 |
Pulse Biosciences (PLSE) | United States | $0.373B | 0.00 |
GenMark Diagnostics (GNMK) | United States | $0.340B | 0.00 |
IRadimed (IRMD) | United States | $0.307B | 65.35 |
Neuronetics (STIM) | United States | $0.306B | 0.00 |
Sientra (SIEN) | United States | $0.301B | 0.00 |
SeaSpine Holdings (SPNE) | United States | $0.294B | 0.00 |
RTI Surgical (RTIX) | United States | $0.290B | 46.50 |
Nuvectra (NVTR) | United States | $0.245B | 0.00 |
Corindus Vascular Robotics (CVRS) | United States | $0.235B | 0.00 |
CRH Medical (CRHM) | Canada | $0.235B | 40.88 |
Helius Medical Technologies (HSDT) | United States | $0.171B | 0.00 |
T2 Biosystems (TTOO) | United States | $0.156B | 0.00 |
Ekso Bionics Holdings (EKSO) | United States | $0.137B | 0.00 |
Sensus Healthcare (SRTS) | United States | $0.125B | 0.00 |
Ra Medical Systems (RMED) | United States | $0.088B | 0.00 |
Titan Medical (TMDI) | Canada | $0.085B | 0.00 |
EDAP TMS (EDAP) | France | $0.082B | 0.00 |
Biosig Technologies (BSGM) | United States | $0.075B | 0.00 |
Apollo Endosurgery (APEN) | United States | $0.072B | 0.00 |
HTG Molecular Diagnostics (HTGM) | United States | $0.066B | 0.00 |
ConforMIS (CFMS) | United States | $0.063B | 0.00 |
Alphatec Holdings (ATEC) | United States | $0.061B | 0.00 |
Vermillion (VRML) | United States | $0.059B | 0.00 |
Second Sight Medical Products (EYES) | United States | $0.056B | 0.00 |
Electromed (ELMD) | United States | $0.049B | 25.43 |
OBALON THERPTCS (OBLN) | United States | $0.048B | 0.00 |
Xtant Medical Holdings (XTNT) | United States | $0.038B | 0.00 |
Microbot Medical (MBOT) | United States | $0.038B | 0.00 |
Viveve Medical (VIVE) | United States | $0.033B | 0.00 |
Navidea Biopharmaceuticals (NAVB) | United States | $0.032B | 0.00 |
Restoration Robotics (HAIR) | United States | $0.032B | 0.00 |
PAVmed (PAVM) | United States | $0.027B | 0.00 |
DarioHealth (DRIO) | Israel | $0.025B | 0.00 |
Lianluo Smart (LLIT) | China | $0.024B | 0.00 |
Neovasc (NVCN) | Canada | $0.019B | 0.00 |
Dynatronics (DYNT) | United States | $0.017B | 0.00 |
American Shared Hospital Services (AMS) | United States | $0.014B | 11.00 |
Bioanalytical Systems (BASI) | United States | $0.014B | 45.67 |
ENDRA Life Sciences (NDRA) | United States | $0.013B | 0.00 |
Nanovibronix (NAOV) | United States | $0.013B | 0.00 |
ReWalk Robotics (RWLK) | Israel | $0.011B | 0.00 |
Avinger (AVGR) | United States | $0.010B | 0.00 |
Presbia (LENS) | Ireland | $0.009B | 0.00 |
Atossa Genetics (ATOS) | United States | $0.009B | 0.00 |
InspireMD (NSPR) | Israel | $0.008B | 0.00 |
Cesca Therapeutics (KOOL) | United States | $0.008B | 0.00 |
Allied Healthcare Products (AHPI) | United States | $0.007B | 0.00 |
Micron Solutions (MICR) | United States | $0.007B | 0.00 |
SINTX TECHNOLOGIES, INC (SINT) | United States | $0.006B | 0.00 |
Sunshine Heart Inc (CHFS) | United States | $0.005B | 0.00 |
Check-Cap (CHEK) | Israel | $0.000B | 0.00 |